Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Stenocare

0.98 DKK-1.01 %24.8, 16.59
Less than 1K followers

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.01 %
-3.45 %
-14.41 %
-31.47 %
-33.78 %
+12.90 %
-50.58 %
-84.86 %
-92.82 %

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Read more
Market cap
42.54M DKK
Turnover
49.8K DKK
Revenue
7.02M
EBIT %
-25.26 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
29.10
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release20.08.2026, 08.00

STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter

Stenocare
Press release07.08.2026, 08.00

STENOCARE: France reaches important milestone towards permanent legalisation of medical cannabis

Stenocare
Press release03.07.2026, 19.37

STENOCARE completes integration of CannGros ApS

Stenocare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release07.05.2026, 08.00

STENOCARE: Interim report first quarter 2026

Stenocare
Regulatory press release29.04.2026, 15.21

STENOCARE: Communiqué from Annual General Meeting

Stenocare
Regulatory press release07.04.2026, 17.45

Notice to Annual General Meeting in STENOCARE A/S

Stenocare
Regulatory press release26.03.2026, 08.17

STENOCARE A/S publishes Annual Report 2025

Stenocare
Regulatory press release26.02.2026, 08.00

STENOCARE: Interim report fourth quarter and Financial Statement Release 2025

Stenocare
Press release11.02.2026, 08.00

STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership

Stenocare
Press release27.01.2026, 16.27

STENOCARE: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany

Stenocare
Regulatory press release30.12.2025, 11.19

Trading in STENOCARE shares by closely related party to board member

Stenocare
Press release21.11.2025, 06.41

BioStock: Stenocare acquires Canngros

Stenocare
Press release19.11.2025, 19.56

STENOCARE share analyst's comments on the CannGros acquisition

Stenocare
Regulatory press release18.11.2025, 09.59

STENOCARE: Correction of total shares issued and total nominal share capital:

Stenocare
Regulatory press release17.11.2025, 17.56

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Regulatory press release17.11.2025, 17.01

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Regulatory press release22.10.2025, 08.00

STENOCARE: Interim report third quarter 2025

Stenocare
Regulatory press release27.08.2025, 21.30

Trading in STENOCARE shares by closely related party to board member

Stenocare
Regulatory press release21.08.2025, 08.00

STENOCARE: Interim report second quarter 2025

Stenocare
Third party research19.05.2025, 10.05

STENOCARE: Time to Capitalize on STENOCARE 3.0 - Analyst Group

STENOCARE A/S (“STENOCARE” or the “Company”) is a medical cannabis trading company with products approved and available for patients in six countries. The Company has recently launched a premium product, Astrum oil, which Analyst Group sees as an important...

Stenocare